Pasar al contenido principal

APROXIMACIONES SISTEMICAS BASADAS EN ASOCIACIONES FENOTIPO-GENOTIPO PARA MEJORAR EL DIAGNOSTICO DE PACIENTES CON ENFERMEDADES RARAS.

PID2019-108096RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE MALAGA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phenotype-genotype comorbidity analysis of patients with rare disorders provides insight into their pathological and molecular bases

  • Díaz-Santiago, Elena
  • Jabato, Fernando M.
  • Rojano, Elena
  • Seoane, Pedro
  • Pazos, Florencio
  • Perkins, James R.
  • Ranea, Juan A. G.
© 2020 Díaz-Santiago et al., Genetic and molecular analysis of rare disease is made difficult by the small numbers of affected patients. Phenotypic comorbidity analysis can help rectify this by combining information from individuals with similar phenotypes and looking for overlap in terms of shared genes and underlying functional systems. However, few studies have combined comorbidity analysis with genomic data. We present a computational approach that connects patient phenotypes based on phenotypic co-occurence and uses genomic information related to the patient mutations to assign genes to the phenotypes, which are used to detect enriched functional systems. These phenotypes are clustered using network analysis to obtain functionally coherent phenotype clusters. We applied the approach to the DECIPHER database, containing phenotypic and genomic information for thousands of patients with heterogeneous rare disorders and copy number variants. Validity was demonstrated through overlap with known diseases, co-mention within the biomedical literature, semantic similarity measures, and patient cluster membership. These connected pairs formed multiple phenotype clusters, showing functional coherence, and mapped to genes and systems involved in similar pathological processes. Examples include claudin genes from the 22q11 genomic region associated with a cluster of phenotypes related to DiGeorge syndrome and genes related to the GO term anterior/posterior pattern specification associated with abnormal development. The clusters generated can help with the diagnosis of rare diseases, by suggesting additional phenotypes for a given patient and potential underlying functional systems. Other tools to find causal genes based on phenotype were also investigated. The approach has been implemented as a workflow, named PhenCo, which can be adapted to any set of patients for which phenomic and genomic data is available. Full details of the analysis, including the clusters formed, their constituent functional systems and underlying genes are given. Code to implement the workflow is available from GitHub., The study was funded by grants from the The Spanish Ministry of Science and Innovation with European Regional Development Fund [PID2019-108096RB-C21 to J.A.G and PID2019- 108096RB-C22 to F.P.]; the Andalusian Government (Junta de Andalucia) with European Regional Development Fund [UMA18-FEDERJA102], and Biomedicine Research project [PI-0075- 2017] (Fundacion Progreso y Salud); and the Ramo´n Areces foundation, which funds project for the investigation of rare disease (National call for research on life and material sciences, XIX edition); Ramo´n y Cajal I3 projects through the Research Plan of the University of Malaga (Ayudas del I Plan Propio). The CIBERER is an initiative from the Carlos III Health Institute (Instituto de Salud Carlos III; ISCIII).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Gene expression analysis method integration and co-expression module detection applied to rare glucide metabolism disorders using ExpHunterSuite

  • Jabato, Fernando M.
  • Córdoba-Caballero, José
  • Rojano, Elena
  • Romá-Mateo, Carlos
  • Sanz, Pascual
  • Pérez, Belén
  • Gallego, Diana
  • Seoane, Pedro
  • Ranea, Juan A. G.
  • Perkins, James R.
12 páginas, 7 figuras, 2 tablas. Te online version contains supplementary material available at https://doi.org/ 10.1038/s41598-021-94343-w . Code is available at the bioconductor landing page https://bioconductor.org/packages/ExpHunterSuite. Te latest version of the code can be found at https://github.com/seoanezonjic/ExpHunterSuite. Tere is a specifc github site for the simulated data and case-studies at: https://github.com/fmjabato/ExpHunterSuiteExamples. Te dataset supporting the results of this article are available in the Sequence Read Archive SRA [https://www.ncbi.nlm.nih.gov/sra/PRJNA746239 (Lafora Disease) and ttps://www.ncbi.nlm.nih.gov/sra/PRJNA747153 (PMM2-CDG)] ; all FASTQ fles as well as important processed data necessary to repeat analysis have been made available., High-throughput gene expression analysis is widely used. However, analysis is not straightforward. Multiple approaches should be applied and methods to combine their results implemented and investigated. We present methodology for the comprehensive analysis of expression data, including co-expression module detection and result integration via data-fusion, threshold based methods, and a Naïve Bayes classifier trained on simulated data. Application to rare-disease model datasets confirms existing knowledge related to immune cell infiltration and suggest novel hypotheses including the role of calcium channels. Application to simulated and spike-in experiments shows that combining multiple methods using consensus and classifiers leads to optimal results. ExpHunter Suite is implemented as an R/Bioconductor package available from https://bioconductor.org/packages/ExpHunterSuite . It can be applied to model and non-model organisms and can be run modularly in R; it can also be run from the command line, allowing scalability with large datasets. Code and reports for the studies are available from https://github.com/fmjabato/ExpHunterSuiteExamples, Tis work was supported by Te Spanish Ministry of Economy and Competitiveness with European Regional Development Fund [PID2019-108096RB-C21]; the Andalusian Government with European Regional Development Fund [projects: UMA18-FEDERJA-102 and PAIDI-2020-PY20-00372]; biomedicine research project [PI-0075-2017] (Fundación Progreso y Salud); the Carlos III Health Institue [PI19/01155]; the Ramón Areces foundation for rare disease investigation (National call for research on life and material sciences, XIX edition); the National Institute of Health (NIH-NINDS) [P01NS097197], which established the Lafora Epilepsy Cure Initiative (LECI); the Madrid Government [B2017/BMD-3721], and the Fundación Isabel Gemio/Fundacion La Caixa [LCF/PR/PR16/11110018]. Te CIBERER is an initiative from the Carlos III Health Institute (Instituto de Salud Carlos III)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrating differential expression, co-expression and gene network analysis for the identification of common genes associated with tumor angiogenesis deregulation

  • Monterde, Beatriz
  • Rojano, Elena
  • Córdoba-Caballero, José
  • Seoane, Pedro
  • Perkins, James R.
  • Medina, Miguel Ángel
  • Ranea, Juan A.G.
Angiogenesis is essential for tumor growth and cancer metastasis. Identifying the molecular pathways involved in this process is the first step in the rational design of new therapeutic strategies to improve cancer treatment. In recent years, RNA-seq data analysis has helped to determine the genetic and molecular factors associated with different types of cancer. In this work we performed integrative analysis using RNA-seq data from human umbilical vein endothelial cells (HUVEC) and patients with angiogenesis-dependent diseases to find genes that serve as potential candidates to improve the prognosis of tumor angiogenesis deregulation and understand how this process is orchestrated at the genetic and molecular level. We downloaded four RNA-seq datasets (including cellular models of tumor angiogenesis and ischaemic heart disease) from the Sequence Read Archive. Our integrative analysis includes a first step to determine differentially and co-expressed genes. For this, we used the ExpHunter Suite, an R package that performs differential expression, co-expression and functional analysis of RNA-seq data. We used both differentially and co-expressed genes to explore the human gene interaction network and determine which genes were found in the different datasets that may be key for the angiogenesis deregulation. Finally, we performed drug repositioning analysis to find potential targets related to angiogenesis inhibition. We found that that among the transcriptional alterations identified, SEMA3D and IL33 genes are deregulated in all datasets. Microenvironment remodeling, cell cycle, lipid metabolism and vesicular transport are the main molecular pathways affected. In addition to this, interacting genes are involved in intracellular signaling pathways, especially in immune system and semaphorins, respiratory electron transport and fatty acid metabolism. The methodology presented here can be used for finding common transcriptional alterations in other genetically-based diseases., This work was supported by the Spanish Ministry of Science, Innovation and Universities (grant PID2019-105010RB-I00, grant PID2019-108096RB-C21), the Andalusian Government and FEDER (grants UMA18-FEDERJA-102, UMA18-FEDERJA-220, PY20_00257, PY20_00372, RH-0079-2021 and funds from the group PAIDI BIO 267); the Spanish Ministry of Economy and Competitiveness (grant PID2019-108096RB-C21), the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union (HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to JAGR. JRP holds a research grant from the Andalusian Government (Fundacion Progreso y Salud) [PI-0075-2017]. BM is awarded of the Ayudas para la formación del profesorado universitario (FPU18/00755, Ministerio de Universidades)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CoMentG: comprehensive retrieval of generic relationships between biomedical concepts from the scientific literature

  • Novoa, Jorge
  • López-Ibáñez, Javier
  • Chagoyen, Mónica
  • Ranea, Juan A. G.
  • Pazos, Florencio
The CoMentG resource contains millions of relationships between terms of biomedical interest obtained from the scientific literature. At the core of the system is a methodology for detecting significant co-mentions of concepts in the entire PubMed corpus. That method was applied to nine sets of terms covering the most important classes of biomedical concepts: diseases, symptoms/clinical signs, molecular functions, biological processes, cellular compartments, anatomic parts, cell types, bacteria and chemical compounds. We obtained more than 7 million relationships between more than 74 000 terms, and many types of relationships were not available in any other resource. As the terms were obtained from widely used resources and ontologies, the relationships are given using the standard identifiers provided by them and hence can be linked to other data. A web interface allows users to browse these associations, searching for relationships for a set of terms of interests provided as input, such as between a disease and their associated symptoms, underlying molecular processes or affected tissues. The results are presented in an interactive interface where the user can explore the reported relationships in different ways and follow links to other resources. Database URL: https://csbg.cnb.csic.es/CoMentG/., Spanish Ministry of Economy and Competitiveness with European Regional Development Fund (grant numbers PID2019-108096RB-C21 and PID2022-140047OB-C21 to J.A.G.R., PID2019-108096RB-C22 and PID2022-1400 47OB-C22 to F.P.); The Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (‘A way to make Europe’); The European Food Safety Authority (grant number GP/EFSA/ENCO/2020/02 to F.P.); and the European Union (grant number HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580 to J.A.G.R.). The conclusions, findings and opinions expressed in this scientific paper reflect only the view of the authors and not the official position of the Euro- pean Food Safety Authority. CIBERER is an initiative from the Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transcriptomic analysis identifies dysregulated pathways and therapeutic targets in PMM2-CDG

  • Gallego, Diana
  • Serrano, Mercedes
  • Cordoba-Caballero, Jose
  • Gámez, Alejandra
  • Seoane, Pedro
  • Perkins, James R.
  • Ranea, Juan A.G.
  • Pérez, Belén
PMM2-CDG (MIM # 212065), the most common congenital disorder of glycosylation, is caused by the deficiency of phosphomannomutase 2 (PMM2). It is a multisystemic disease of variable severity that particularly affects the nervous system; however, its molecular pathophysiology remains poorly understood. Currently, there is no effective treatment. We performed an RNA-seq based transcriptomic study using patient-derived fibroblasts to gain insight into the mechanisms underlying the clinical symptomatology and to identify druggable targets. Systems biology methods were used to identify cellular pathways potentially affected by PMM2 deficiency, including Senescence, Bone regulation, Cell adhesion and Extracellular Matrix (ECM) and Response to cytokines. Functional validation assays using patients' fibroblasts revealed defects related to cell proliferation, cell cycle, the composition of the ECM and cell migration, and showed a potential role of the inflammatory response in the pathophysiology of the disease. Furthermore, treatment with a previously described pharmacological chaperone reverted the differential expression of some of the dysregulated genes. The results presented from transcriptomic data might serve as a platform for identifying therapeutic targets for PMM2-CDG, as well as for monitoring the effectiveness of therapeutic strategies, including pharmacological candidates and mannose-1-P, drug repurposing., This work was funded the Instituto de Salud Carlos (ISCIII), European Regional Development Fund [PI22/00699] to BP. The Spanish Ministry of Economy and Competitiveness (grants PID2019-108096RB-C21 and PID2022-140047OB C21), the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union (HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to JAGR. The “CIBER de Enfermedades Raras” is an initiative from the ISCIII (Spain).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Exploring miRNA-target gene pair detection in disease with coRmiT

  • Córdoba-Caballero, José
  • Perkins, James R.
  • García-Criado, Federico
  • Gallego, Diana
  • Navarro-Sánchez, Alicia
  • Moreno-Estellés, Mireia
  • Garcés, Concepción
  • Bonet, Fernando
  • Romá-Mateo, Carlos
  • Toro, Rocío
  • Pérez, Belén
  • Sanz, Pascual
  • Kohl, Matthias
  • Rojano, Elena
  • Seoane, Pedro
  • Ranea, Juan A. G.
13 páginas, 8 figuras, 1 tabla, A wide range of approaches can be used to detect micro RNA (miRNA)-target gene pairs (mTPs) from expression data, differing in the ways the gene and miRNA expression profiles are calculated, combined and correlated. However, there is no clear consensus on which is the best approach across all datasets. Here, we have implemented multiple strategies and applied them to three distinct rare disease datasets that comprise smallRNA-Seq and RNA-Seq data obtained from the same samples, obtaining mTPs related to the disease pathology. All datasets were preprocessed using a standardized, freely available computational workflow, DEG_workflow. This workflow includes coRmiT, a method to compare multiple strategies for mTP detection. We used it to investigate the overlap of the detected mTPs with predicted and validated mTPs from 11 different databases. Results show that there is no clear best strategy for mTP detection applicable to all situations. We therefore propose the integration of the results of the different strategies by selecting the one with the highest odds ratio for each miRNA, as the optimal way to integrate the results. We applied this selection-integration method to the datasets and showed it to be robust to changes in the predicted and validated mTP databases. Our findings have important implications for miRNA analysis. coRmiT is implemented as part of the ExpHunterSuite Bioconductor package available from https://bioconductor.org/packages/ExpHunterSuite., This work is supported by funds from Spanish Ministry of Economy and Competitiveness [PID2019-108096RB-C21 and PID2022-140047OB-C21]; the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union through the project EURAS, Grant Agreement No: 101080580, Horizon Europe. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency.Neither the European Union nor the granting authority can be held responsible for them. (HORIZONHLTH-2022-DISEASE-06); Biomedicine research projects [PI-00752017 and PEER-0019-2020](FoundationProgreso y Salud).CIBERER is an initiative from the Institute of Health Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A text mining and ontology-based approach using phenotypes to obtain relevant literature for rare diseases

  • Pérez-García, Jesús
  • García-Criado, Federico
  • Pazos, Florencio
  • Chagoyen, Mónica
  • Rojano, Elena
  • Seoane, Pedro
  • Ranea, Juan A. G.
Diagnosing rare diseases remains a major challenge due to limited clinical knowledge and the frequent absence of diagnostic criteria. We present a digital framework that leverages large language models and biomedical text embeddings to bridge this gap. By mapping Human Phenotype Ontology terms to a shared vector space with millions of PubMed abstracts and full-text articles, our method enables phenotype-driven semantic search and ranks literature relevant to patient symptoms, even without explicit disease mentions. Validated on OMIM-derived benchmarks and applied to RASopathies, including NF1, Noonan, and Costello syndromes, our approach retrieved expected findings, supporting differential diagnosis and research. The framework is implemented in an open-source Python package, py-semtools, and it can be integrated into clinical decision support systems or adapted to other ontologies and corpora. This work demonstrates how AI-driven informatics can enhance rare disease diagnosis and exemplifies the role of digital tools in transforming precision medicine and healthcare delivery., This work is supported by funds from Spanish Ministry of Economy and Competitiveness [PID2019-108096RB-C21 and PID2022-140047OB-C21, PID2022-140047OB-C22]; the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”); and the European Union through the project EURAS (Horizon Europe HORIZON-HLTH-2022-DISEASE-06, Project ID: 101080580) to J.A.G.R. The EURAS project receives funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement no. 101080580 (HORIZON-HLTH-2022-DISEASE-06). Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. Biomedicine research projects [PI-0075-2017 and PEER-0019-2020] are funded by Fundación Progreso y Salud. E.R. hold a research grant from the Instituto de Investigación Biomédica de Málaga (IBIMA-Plataforma BIONAND) [PI RARE 24-03]. J.P.G. is a predoctoral researcher from “ayudas para contratos predoctorales para la formación de doctores” (PRE2022/000510) supported by the Ministerio de Ciencia, Innovación y Universidades. F.G.C. is a predoctoral researcher from “ayudas para contratos predoctorales para la Formación del Profesorado Universitario” (FPU21/01449) supported by the Ministerio de Ciencia, Innovación y Universidades. The “CIBER de Enfermedades Raras” is an initiative from the ISCIII (Spain). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors thank the Supercomputing and Bioinnovation Center (SCBI) of the University of Málaga for their provision of computational resources and technical support (http://www.scbi.uma.es/site). We thank to Junta de Andalucía its support to PAIDI BIO-267 group., Peer reviewed